Chronic cough, defined as a cough persisting for more than eight weeks, presents a diagnostic challenge to clinicians due to its multifactorial etiology. This article outlines a comprehensive approach to diagnosing and treating this common yet perplexing condition.
Initial evaluation should focus on common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). History taking and physical examination can guide further investigations, including chest radiography, spirometry, and testing for GERD. If these investigations are inconclusive, rarer causes such as bronchiectasis, lung cancer, and non-asthmatic eosinophilic bronchitis should be considered.
Treatment should be tailored to the underlying cause. In cases of GERD, proton pump inhibitors and lifestyle modifications are first-line therapies. For asthma-related cough, inhaled corticosteroids and bronchodilators are recommended. Antihistamines and decongestants can alleviate UACS symptoms. If the cough remains unresponsive, referral to a specialist may be necessary for further diagnostic testing and treatment.
A multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists can provide a comprehensive evaluation and treatment plan. This collaborative approach can lead to improved patient outcomes and satisfaction.
The development of new diagnostic tools and treatments, including molecular markers and targeted therapies, may revolutionize the management of chronic cough. Further research is needed to validate these promising advances.
Chronic cough is a complex condition requiring a systematic and comprehensive approach to diagnosis and treatment. By considering common and rarer causes, tailoring treatment to the underlying etiology, and utilizing a multidisciplinary team, clinicians can effectively manage this challenging condition. Continued research into novel diagnostic and therapeutic strategies will further enhance our ability to treat chronic cough.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation